______________________________________________________
[OpDis Editor Note: This was the plan all along right? Create a virus, release it, let it spread, create a vaccine, make money, create a drug for it, make more money. C---D will eventually be treated like the Flu.]
Source: Bangkok Post
PUBLISHED : 5 NOV 2021 AT 19:55
Pfizer says C---d pill 89% effective
CEO calls new medication a ‘game changer’, FDA approval to be sought
WRITER: AFP
WASHINGTON: Pfizer said on Friday that a clinical trial of its pill to treat C---d-19 had shown it is highly effective.
The drug called Paxlovid is the second anti-C---d pill after that of Merck, which is actually an influenza medicine rebranded to fight the coronavirus. Pfizer said its medication had been created specifically to fight C---d.
Advertisement
______________________________________________________
The drug achieved an 89% reduction in risk of hospitalisation or death among adult patients with C---d who are at high risk of progressing to severe illness, the US company said.
The results from the middle- to late-stage clinical trial were so strong that Pfizer will stop recruiting new people for the trial, the company said.
It will submit the data to the Food and Drug Administration as soon as possible as part of its “rolling submission” for Emergency Use Authorisation.
“Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic,” said Pfizer CEO Albert Bourla.
“These data suggest that our oral antiviral candidate, if approved or authorised by regulatory authorities, has the potential to save patients’ lives, reduce the severity of C---d-19 infections, and eliminate up to nine out of 10 hospitalisations.”
The main analysis of the data looked at numbers from 1,219 adults in North and South America, Europe, Africa and Asia.
Several companies are working on oral antivirals, which would mimic what the drug Tamiflu does for influenza and prevent the disease from progressing to severe.
Advertisement
______________________________________________________
Pfizer started developing its drug in March 2020.
Britain on Thursday became the first country to approve an anti-C---d pill, as it okayed the use of Merck’s antiviral drug called molnupiravir to treat patients suffering from mild to moderate coronavirus.
Pfizer’s product is known as a “protease inhibitor” and has been shown in lab testing to jam up the virus’ replication machinery. If it works in real life, it will likely only be effective at the early stages of infection.
By the time C---d progresses to a severe disease, the virus has largely stopped replicating and patients suffer from an overactive immune response.
A simple pill to treat the coronavirus has been sought since the start of the pandemic.
Until now, C---d therapeutics such as monoclonal antibodies and remdesivir — a drug made by Gilead and authorised for use in the EU under the name Veklury — have been administered intravenously.
Molnupiravir was initially developed as an inhibitor of influenza and respiratory syncytial virus — two other important acute respiratory infections — by a team at Emory University in Atlanta, Georgia.
Britain, which has been one of the countries hardest hit by the pandemic, announced on Oct 20 that it had ordered 480,000 doses of molnupiravir.
______________________________________________________
Contact Author
If you wish to contact the author of this article. Please email us at [voyagesoflight@gmail.com]. Availability of author’s contact information depends on if said article was user submitted or reposted.
______________________________________________________
Guest Posting
If you wish to write and/or publish an article on Operation Disclosure all you need to do is send your entry to [voyagesoflight@gmail.com] applying these following rules.
The subject of your email entry should be: “Entry Post | (Title of your post) | Operation Disclosure”
– Must be in text format
– Proper Grammar
– No foul language
– Your signature/name/username at the top
______________________________________________________
Newsletter
If you wish to receive the daily Operation Disclosure Newsletter, you can subscribe via the PayPal “Subscribe” button located at the bottom.
______________________________________________________
Our mission at Operation Disclosure is to get you up-to-date on the latest conspiracies and geopolitics. We also aim to provide raw unvetted information about world events from various sources and user submitted research on topics such as exopolitics, extraterrestrial and UFO/UAP sightings, secret space programs, and the lost or ancient origins and history of humanity.
Disclaimer: All articles, videos, and images posted on Operation Disclosure were submitted by readers and/or handpicked by the site itself for informational and/or entertainment purposes. All statements, claims, views, and opinions that appear on this site are always presented as unverified and should be discerned by the reader. We do not endorse any opinions expressed on this website and we do not support, represent or guarantee the completeness, truthfulness, accuracy, or reliability of any content posted on this website.
Copyright © Operation Disclosure
